Tahir Misbah

CIK 00017873592 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001787359

Recent Transactions

47 trades

Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2026-03-02+20,000→ 20,000 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-02+40,000→ 40,000 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-09-02+325,000→ 325,000 total
Sale
IGM Biosciences, Inc.
Common Stock
2025-07-23$1.27/sh−8,741→ 170,061 total
Sale
IGM Biosciences, Inc.
Common Stock
2025-06-16$1.20/sh−1,522→ 178,802 total
Sale
IGM Biosciences, Inc.
Common Stock
2025-03-14$1.23/sh−7,329→ 180,324 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-12-16$7.48/sh−1,708→ 187,653 total
Award
IGM Biosciences, Inc.
Common Stock
2024-11-18+66,667→ 189,361 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-09-13$11.54/sh−1,487→ 122,694 total
Award
IGM Biosciences, Inc.
Common Stock
2024-07-19+2,222→ 124,181 total
Disposition to Issuer
IGM Biosciences, Inc.
Stock Option (right to buy)
2024-07-19−55,000→ 0 total
Disposition to Issuer
IGM Biosciences, Inc.
Stock Option (right to buy)
2024-07-19−40,000→ 0 total
Award
IGM Biosciences, Inc.
Common Stock
2024-07-19+33,111→ 121,959 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-06-14$7.58/sh−1,570→ 88,848 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-03-14$10.17/sh−2,543→ 90,418 total
Sale
IGM Biosciences, Inc.
Common Stock
2024-03-13$9.88/sh−2,897→ 92,961 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2024-03-12+92,500→ 92,500 total
Award
IGM Biosciences, Inc.
Common Stock
2024-03-12+46,250→ 95,858 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-11-27$5.06/sh−1,337→ 49,608 total
Award
IGM Biosciences, Inc.
Common Stock
2023-11-15$11.71/sh+234→ 50,945 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-05-23$13.01/sh−15→ 50,711 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-05-23$12.30/sh−1,244→ 50,726 total
Award
IGM Biosciences, Inc.
Common Stock
2023-05-15$11.71/sh+398→ 51,970 total
Award
IGM Biosciences, Inc.
Common Stock
2023-04-04+26,250→ 51,572 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2023-04-04+52,500→ 52,500 total
Sale
IGM Biosciences, Inc.
Common Stock
2023-03-14$18.73/sh−1,768→ 25,322 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-12-19$20.00/sh−3,801→ 27,090 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-12-16$18.77/sh−1,468→ 31,706 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-12-16$19.36/sh−815→ 30,891 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-11-23$21.38/sh−600→ 33,451 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-11-23$21.99/sh−277→ 33,174 total
Award
IGM Biosciences, Inc.
Common Stock
2022-11-15$12.84/sh+353→ 34,051 total
Sale
IGM Biosciences, Inc.
Common Stock
2022-05-26$17.10/sh−950→ 33,698 total
Award
IGM Biosciences, Inc.
Common Stock
2022-05-13$12.38/sh+391→ 34,648 total
Award
IGM Biosciences, Inc.
Common Stock
2022-03-15+6,084→ 34,257 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2022-03-12+75,000→ 75,000 total
Award
IGM Biosciences, Inc.
Common Stock
2022-03-12+12,500→ 28,173 total
Award
IGM Biosciences, Inc.
Common Stock
2021-11-15+10,000→ 15,673 total
Award
IGM Biosciences, Inc.
Common Stock
2021-11-15$50.99/sh+86→ 5,673 total
Award
IGM Biosciences, Inc.
Common Stock
2021-05-14$45.90/sh+45→ 5,587 total
Exercise/Conversion
IGM Biosciences, Inc.
Stock Option (right to buy)
2021-03-05−2,750→ 120,097 total
Exercise/Conversion
IGM Biosciences, Inc.
Common Stock
2021-03-05$1.39/sh+2,750→ 5,542 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2021-02-19+40,000→ 40,000 total
Exercise/Conversion
IGM Biosciences, Inc.
Common Stock
2020-12-21$1.39/sh+2,750→ 2,792 total
Exercise/Conversion
IGM Biosciences, Inc.
Stock Option (right to buy)
2020-12-21−2,750→ 122,847 total
Award
IGM Biosciences, Inc.
Common Stock
2020-11-13$45.45/sh+42→ 42 total
Award
IGM Biosciences, Inc.
Stock Option (right to buy)
2020-02-05+55,000→ 55,000 total

Companies

Recent Filings

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov